Global Deep Brain Stimulation Market, By Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s Disease, Others), End-Use (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers) – Industry Trends and Forecast to 2031.
Deep Brain Stimulation Market Analysis and Size
As per the recent data the incidence of Parkinson's disease tends to increase with age, and it is estimated to be around 15-20 per 100,000 people per year in the general population. However, these figures can vary by region and demographic factors. Also, Essential tremor is one of the most common movement disorders. The incidence increases with age, and it is estimated to be around 5 per 1,000 people per year, but again, these rates can vary; Dystonia, a type of deep brain stimulator disease, is less common than Parkinson's disease and essential tremor. The incidence varies depending on the specific type of dystonia and its underlying causes. General estimates suggest a prevalence of about 30-732 cases per million individuals.
Data Bridge Market Research analyzes that the global deep brain stimulation market, which was USD 649.67 million in 2023, is likely to reach USD 1,247.75 million by 2031 and is expected to undergo a CAGR of 8.5% during the forecast period. “Single channel deep brain stimulator” dominates the product segment of the market due to the growing demand for better methods for treatment in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s Disease, Others), End-Use (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East & Africa
|
|
Market Players Covered
|
Medtronic (Ireland), Boston Scientific Corporation (U.S.), Abbott (U.S.), Cyberonics, Inc. (U.S.), Nevro Corp. (U.S.), NeuroSigma, Inc. (U.S.), NeuroPace, Inc. (U.S.), Synapse Biomedical Inc. (U.S.), Neuronetics (U.S.), ReShape Lifesciences, Inc. (U.S.), Zynex Medical (U.S.), Functional Neuromodulation Ltd. (Canada), MicroTransponder Inc. (U.S.), Aleva Neurotherapeutics SA (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
Deep brain stimulation (DBS) refers to a device used for the purpose of providing electrical incitement to some areas of the brain to control the movement. They are extensively utilized to treat diseases such as Parkinson’s disease, chronic pain, central pain syndrome, epilepsy and obsessive compulsive disorder among others.
Global Deep Brain Stimulation Market Dynamics
Drivers
- Increasing Prevalence of Neurological Disorders
DBS is primarily used to treat neurological disorders such as Parkinson's disease, essential tremor, and dystonia. As the prevalence of these disorders continues to rise globally, the demand for DBS as a therapeutic intervention also increases.
- Advancements in Technology
Continuous advancements in deep brain stimulation technology, including improvements in electrode design, surgical techniques, and programming algorithms, contribute to the market growth. Enhanced technology often leads to better treatment outcomes and increased patient acceptance.
Opportunities
- Expansion of Indications
There is an opportunity to explore and expand the applications of DBS beyond its current indications. Research and clinical trials are ongoing to assess the efficacy of DBS in treating conditions such as epilepsy, depression, obsessive-compulsive disorder (OCD), and other neuropsychiatric disorders.
- Personalized Medicine and Precision Targeting
Advances in understanding the individualized nature of neurological disorders create opportunities for personalized medicine in DBS. Tailoring stimulation parameters and targeting specific brain regions based on the unique characteristics of each patient can optimize treatment outcomes.
Restraints/Challenges
- High Cost of Treatment
The cost associated with DBS procedures, including the surgical implantation of electrodes and the required follow-up care, can be substantial. This high cost may limit access to DBS for some patients and pose challenges for widespread adoption.
- Limited Understanding of Mechanisms of Action
The exact mechanisms of action of DBS are not fully understood, and the effects on neural circuits are complex. This lack of clarity may hinder the optimization of stimulation parameters and the development of more targeted and effective treatments.
This deep brain stimulation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the deep brain stimulation market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.
Global Deep Brain Stimulation Market Scope
The deep brain stimulation market is segmented on the basis of product, type, application and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Single Channel Deep Brain Stimulator
- Dual Channel Deep Brain Stimulator
Type
- Subthalamic DBS
- Globus Pallidus DBS
- Thalamic DBS
- Pedunculopontine Nucleus DBS
Application
- Pain Management
- Epilepsy
- Essential Tremor
- Obsessive-Compulsive Disorder (OCD)
- Depression
- Dystonia
- Parkinson’s Disease
- Others
End-Use
- Hospitals
- Neurology Clinics
- Ambulatory Surgical Centers
- Research Centers
Global Deep Brain Stimulation Market Regional Analysis/Insights
The deep brain stimulation market is analyzed and market size insights and trends are provided by country, product, type, application and end-use as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East & Africa.
North America is expected to dominate the market due to the increase in FDA approvals for deep brain stimulation devices in clinical applications, government funding and initiatives for raising awareness about movement disorders and rise in patients diagnosed with PD in the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the prevalence of neurodegenerative disorders, demand for effective and long-term solutions, improvements in the clinical development framework and growth in awareness about neurological disease treatment options in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The deep brain stimulation market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the deep brain stimulation market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the deep brain stimulation market.
Competitive Landscape and Deep Brain Stimulation Market Share Analysis
The deep brain stimulation market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the deep brain stimulation market.
Some of the major players operating in the deep brain stimulation market are:
- Medtronic (Ireland)
- Boston Scientific Corporation (U.S.)
- Abbott (U.S.)
- Cyberonics, Inc. (U.S.)
- Nevro Corp. (U.S.)
- NeuroSigma, Inc. (U.S.)
- NeuroPace, Inc. (U.S.)
- Synapse Biomedical Inc. (U.S.)
- Neuronetics (U.S.)
- ReShape Lifesciences, Inc. (U.S.)
- Zynex Medical (U.S.)
- Functional Neuromodulation Ltd. (Canada)
- MicroTransponder Inc. (U.S.)
- Aleva Neurotherapeutics SA (Switzerland)
SKU-